Botulism, caused by a nerve toxin, is a very rare but serious condition that causes paralysis. The nerve toxin is caused by Clostridium botulinum which is a type of bacteria that can be found in the soil and low-oxygenated areas. There are three common types of botulism. Occurring in about 15% of cases, Foodborne botulism is caused by botulinum toxin contaminated foods. Occurring about 20% of the time, Wound botulism is caused when a wound is infected with the bacteria and then the toxin is produced. Infant botulism, occurring 65% of the time, is caused when the infant consumes the bacteria which then grows in their intestines and releases the toxin. Symptoms of botulism include muscle weakness, dry mouth, and double vision. Botulism is treated with antitoxins and antibiotics, and the death rate due to botulism has dropped from 50% to 3-5% in the last 50 years.
Botulism Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Botulism below!
For more information on how to use Laverne, please read the How to Guide.
We have 768 products for the study of Botulism that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Botulism is also known as botulism, intoxication with clostridium botulinum toxin, food poisoning due to clostridium botulinum, infection due to clostridium botulinum, foodborne botulism (subtype), infant botulism (subtype), wound botulism (subtype), botulism (disorder), botulism poisoning, foodborne botulism, infection.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.